Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
1. 系统已在2025-12-18 16:42:12对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1470-2045(25)00465-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525004656
其他信息:
出版社: Elsevier BV
作者: Thorsten Fuereder; Javier Garde-Noguera; Juan José García-Mosquera; Manuel Ruiz-Borrego; María Valero; Antonio Llombart-Cussac; María Gion; Richard Greil; Miriam Arumi; Marta Campolier; José Antonio Guerrero; Giulia Raimondi; Mario Mancino; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Maximilian Marhold; Anna Sophie Berghoff; Julia Furtner; Rupert Bartsch; Matthias Preusser
